Opinion: Mark Cuban’s company won’t fix drug costs, but it can still help rectify America’s drug shortages
Americans are facing at least two prescription drug crises simultaneously. One is the outrageously high cost of drugs, which runs to more than $500 billion per year. The other relates to extreme drug shortages requiring rationing of lifesaving medications.
Crises can generate opportunities. Mark Cuban, the wildly successful entrepreneur and NBA owner, has committed himself to solving these two problems. Through the creation of the Mark Cuban Cost Plus Drug Company (MCCPDC), Cuban aims to reduce drug prices and also drug shortages.
